Endocrinology · Acibadem Fulya Hospital, İstanbul Prof. Rüştü Serter, MD
✓ Medically verified profileProf. Rüştü Serter, MD
Prof. Rüştü Serter, MD is an endocrinology specialist at Acibadem Fulya Hospital in İstanbul, working in the Endocrinology & Metabolism unit. His practice covers diabetes, endocrine and metabolic diseases, obesity, nutrition and internal medicine. He has more than 40 years in medicine, consults in Turkish and English, and offers video consultation for international patients.
Accepting international patientsAbout Prof. Rüştü Serter, MD
Prof. Rüştü Serter, MD is an endocrinology specialist at Acibadem Fulya Hospital in İstanbul, where he works within the Endocrinology & Metabolism unit. His practice covers diabetes, endocrine and metabolic diseases, obesity, nutrition and internal medicine. Dr. Serter has more than 40 years in medicine and consults in Turkish and English.
He graduated from Hacettepe University Faculty of Medicine in 1986 and worked at Gaziantep S.S.K. Dispanseri from 1986 to 1987. Between 1987 and 1991 he completed specialty training in internal medicine (İç Hastalıkları) at Ankara Eğitim ve Araştırma Hospital, where he then served as Chief Assistant from 1991 to 1993. From 1993 to 1996 he undertook subspecialty training (Yan Dal Uzmanlığı) in the Endokrinoloji ve Metabolizma Kliniği of the same hospital and became an Associate Professor in 1996. He continued at Ankara Eğitim ve Araştırma Hospital as Chief Assistant in the endocrinology and metabolism clinic (1996–1998) and as deputy chief (Şef Yardımcısı) from 1998 to 2005. In 2005–2006 he was clinic chief (Klinik Şef) of internal medicine at Ankara Onkoloji Eğitim ve Araştırma Hospital, and from 2006 to 2010 he held the same role at Ankara Eğitim ve Araştırma Hospital İç Hastalıkları. He joined Acıbadem Healthcare Services in 2010. Dr. Serter is a member of the Diabetes Federation (IDF), the European Society of Endocrinology (ESE), the European Association for the Study of Diabetes (EASD), the Mediterranean Group for the Study of Diabetes (MGSD), the Turkish Endocrinology and Metabolism Association, the Obesity, Nutrition and Diabetes Association, the National Nutrition Platform Association, the Türkiye Diyabet Vakfı Mütevelli Heyeti and the Turkish Obesity Foundation. He edited the book Metabolic Syndrome (Scientific Medicine Publishing House, Ankara, 2008), and his published work includes studies on L-thyroxine replacement in hypothyroidism, adiponectin and insulin resistance in polycystic ovary syndrome, Helicobacter pylori in diabetic patients and the treatment of hirsutism.
Clinical focus
Dr. Serter evaluates and manages diabetes and a range of endocrine and metabolic diseases. His background in internal medicine informs the assessment of patients whose metabolic conditions coexist with other medical problems. Nutrition is part of his approach to care, and he is involved in national organizations concerned with obesity, nutrition and diabetes.
He also sees patients with obesity, where evaluation considers weight-related metabolic factors alongside the patient’s overall health. Treatment planning is based on the individual clinical picture, and the appropriate approach is determined after examination and review of the relevant test results.
How Dr. Serter works with international patients
Dr. Serter consults in Turkish and English, and interpreters can be arranged for other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports, including laboratory results, imaging reports and discharge summaries, and arranges appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing test results and previous treatments, a clinical examination and a discussion of the options. Video consultation is available for international patients who wish to have an initial discussion before traveling.
What Dr. Serter treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Areas of practiceNutrition
Conditions treated
- Diabetic ketoacidosis
- Diabetes insipidus
- Type 1 diabetes
- Endocrine and metabolic diseases
- Obesity
- Internal medicine
Procedures performed
Education, career and memberships
Education & training
Education
- 1996Ankara Eğitim ve Araştırma Hospital / Associate Professor
- 1996Ankara Eğitim ve Araştırma Hospital Endokrinoloji ve Metabolizma Hastalıkları
- 1991Ankara Eğitim ve Araştırma Hospital İç Hastalıkları
- 1986Hacettepe University Faculty of Medicine
Career
Professional Experience
- 2010Acıbadem Healthcare Services
- 2006–2010Ankara Eğitim ve Araştırma Hospital İç Hastalıkları, Klinik Şef
- 2005–2006Ankara Onkoloji Eğitim ve Araştırma Hospital İç Hastalıkları, Klinik Şef
- 1998–2005Ankara Eğitim ve Araştırma Hospital Endokrinoloji ve Metabolizma Kliniği, Şef Yardımcısı
- 1996–1998Ankara Eğitim ve Araştırma Hospital Endokrinoloji ve Metabolizma Kliniği, Chief Assistant
- 1993–1996Ankara Eğitim ve Araştırma Hospital Endokrinoloji ve Metabolizma Kliniği, Yan Dal Uzmanlığı
- 1991–1993Ankara Eğitim ve Araştırma Hospital İç Hastalıkları, Chief Assistant
- 1987–1991Ankara Eğitim ve Araştırma Hospital İç Hastalıkları,Uzmanlık Eğitimi
- 1986–1987Gaziantep S.S.K. Dispanseri
Memberships
Professional Memberships
- Diabetes Federation (IDF)
- European Society of Endocrinology (ESE)
- European Association for the Study of Diabetes (EASD)
- Mediterranean Group for the Study of Diabetes (MGSD)
- Turkish Endocrinology and Metabolism Association
- Obesity, Nutrition and Diabetes Association
- National Nutrition Platform Association
- Türkiye Diyabet Vakfı Mütevelli Heyeti
- Turkish Obesity Foundation
Selected publications
Selected Publications
- A case with Fever of Unknown Origin Diagnosed as Wegener’s Granulomatosis. Turkish Journal of Rheumatology; 25(3): 159-161,2010 Bayrak E, Donderici O, Serter R, et al.
- Serum Fibroblast growth factor 21 Levels in Polycystic Ovary Syndrome. Gynecological Endocrinology 26(11): 819-826,2010 Gorar S, Culha C, Uc Z, Dellal F, Serter R, Aral S, Aral Y.
- Effects of L-thyroxine Replacement Therapy on Carotid Intima-media Thickness in Patients with Primary Hypothyroidism. Cakal E, Turgut AT, Demirbas B, Ozkaya M, Cakal B, Serter R, Aral Y. Exp Clin Endocrinol Diabetes 2009 ; 117: 294
- Association of Hypoadiponectinemia with Metabolic Syndrome in Patients with Polycystic Ovary Syndrome. Gulcelik NE, Aral Y, Serter R, Koc G, Journal of the National Medical Association;100(1):64-68,2008
- Association of Hypoadiponectinemia with Metabolic Syndrome in Patients with Polycystic Ovary Syndrome. Gulcelik NE, Aral Y, Serter R, Koc G. Journal of the National Medical Association;100(1):64-68,2008
- Metabolic Syndrome (book). R.Serter (editor). Scientific Medicine Publishing House; Ankara,2008
- Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol cyproterone acetate in the treatment of hirsutism: A randomized controlled study. Adv Ther. 2008; 25(4): 321-328,2008 Karakurt F, Sahin I, Guler S, Demirbas B, Culha C, Serter R, Aral Y, Bavbek N.
- Homocysteine and Fibrinogen changes with L-thyroxine in subclinical Hypothyroid patients. J Korean Med Sci; 22: 431-5,2007 Cakal B, Cakal E, Demirbas B, Ozkaya M, Karaahmetoglu S, Serter R, Aral Y.
- Adiponectin is an independent determinant of insulin resistance in women withpolicystic ovary Syndrome. Gulcelik NE, Aral Y, Serter R, Demir Y, Culha C, Gynecol Endocrinol. 22(9):511-5,2006
- Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M, Cakal E, Serter R, Aral Y, J Endocrinol Invest. 28:214-217,2005
- The effect of L-thyroxine replacement therapy on lipid-based cardiovascular risk in subclinical hypothyroidism Serter R, Demirbas B, Korukluoglu B, Culha C, Cakal E, Aral Y. J Endocrinol Invest. 27:897-903,2004
